Bioavailability of Folate From a Mixed Diet Using a Stable Isotope Method

NCT ID: NCT00130585

Last Updated: 2005-10-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-05-31

Study Completion Date

2005-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objectives of this project are:

1. to determine the relative bioavailability of dietary folate from a total diet, compared with synthetic folic acid and
2. to determine the bioavailability with a higher precision than previous methods.

The hypothesis is that the bioavailability of dietary folate within a confidence interval of +/-20% can be estimated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Folate plays a role in the prevention of certain birth defects and possibly also in prevention of neurocognitive diseases, cancer and cardiovascular disease. The proportion of dietary folate that is absorbed and becomes available for metabolic processes in the body has been estimated between 30 and 98%, but an accurate figure is lacking. Since subjects generally differ a lot in their folate or homocysteine response upon a change in dietary folate intake, the between-person variability in these responses is high. Therefore, bioavailability estimates derived from these responses have large confidence intervals. With this trial the researchers want to determine folate bioavailability with a higher precision than previous trials. A good estimate of folate bioavailability from the general diet is necessary to construct reliable dietary reference intakes for folate.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Folate Bioavailability Healthy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Folate Bioavailability Stable isotopes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Controlled diet

Intervention Type BEHAVIORAL

folic acid supplement

Intervention Type BEHAVIORAL

13C11-labelled folic acid supplement

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Serum B12 \>118pmol/L;
* Serum creatinine \<125micromol/L;
* Plasma total homocysteine \<26micromol/L.

Exclusion Criteria

* Cardiovascular disease, cancer, rheumatoid arthritis, epilepsy, gastro-intestinal disorders;
* Use of drugs interfering with folate metabolism;
* Use of B vitamins within the period three months prior to the study.
* Body Mass Index (BMI) \> 30
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wageningen University

OTHER

Sponsor Role collaborator

Wageningen Centre for Food Sciences

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Petra Verhoef, Dr.

Role: PRINCIPAL_INVESTIGATOR

Wageningen Centre for Food Sciences

Martijn Katan, Professor

Role: PRINCIPAL_INVESTIGATOR

Wageningen University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Wageningen University

Wageningen, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A-007-RW

Identifier Type: -

Identifier Source: org_study_id